Experimental studies using a diethylnitrosamine-induced hepatocellular carcinoma model have demonstrated that IL-6 promotes compensatory proliferation of hepatocytes, and its absence or inhibition of IL-6 receptor-related proteins impedes liver tumor development (23). The gene discussed is IL6; the disease is hepatocellular carcinoma.